Healthcare Industry Events
How To: Hands-On Testing of Medical Devices
Overview The tragic death of a young child in a Philadelphia emergency room, caused by a malfunctioning medical device, gave birth to a new kind of organization fiercely committed to the safety...
Clinical Practice Guideline Development: Key Factors to Consider Using GRADE
Overview Clinical practice guidelines make recommendations about many aspects of patient care: risk assessment, diagnosis, prognosis, treatment, monitoring, and follow-up. Some recommendations ...
Errors Associated with Oxytocin
Intravenous (IV) oxytocin used antepartum is indicated to induce labor in patients with a medical indication to stimulate or reinforce labor in selected cases of uterine inertia and as an adjunct i...
PSOs and Litigation: Maximize Your Protections
Overview Healthcare providers are challenged to protect sensitive patient safety information, while performing essential safety, risk, and quality work. Patient Safety Organizations (PSOs) can ...
Environmental Cleaning and Disinfection: Break the Chain of Infection
Overview Over the course of the last three years, infection prevention and healthcare technology management leaders needed to rapidly adjust to prevent the spread of SARS-CoV-2. Now, with the c...
Navigating Staffing Shortages: How PSOs as Learning Systems can Reduce Risks
Overview Staffing shortages pose a significant challenge to healthcare organizations. While the strain of caring for COVID-19 patients continues to decrease as the number of case drop, hospital...
Implementation science aims to discover and apply strategies that accelerate successful integration of interventions into routine practice. This initiative will provide background information on th...
The term “polypharmacy” most commonly refers to a situation where a patient is being treated with many, five or more, medications. Patients of all ages may potentially receive many medications. The...
Errors Associated with Paxlovid
Paxlovid was authorized under the emergency use authorization (EUA) by the US Food and Drug Administration (FDA) in December 2021 and is used for mild-to-moderate coronavirus 2019 (COVID-19) in ad...